METALS-CO/BJARKE-INGELS
12.5.2021 09:02:14 CEST | Business Wire | Press release
BIG-Bjarke Ingels Group , the acclaimed global architecture firm whose groundbreaking work incorporates innovations in architecture, has collaborated with The Metals Company , a developer of lower-impact battery metals from seafloor polymetallic nodules, to remake conventional metal production for the 21st century as society embarks on the transition to a net-zero-carbon future. The Metals Company announced in March that it will merge with Sustainable Opportunities Acquisition Corporation (NYSE:SOAC ) to go public on the NASDAQ in Q2 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210512005310/en/
The Metals Company’s challenge with BIG was to bring innovative, whole-systems design to the industrial components needed to supply the world with critical battery metals from polymetallic nodules—fist-sized rocks containing battery-grade nickel, cobalt, copper and manganese—while reimagining the nexus of industry and community. BIG delivered an integrated suite of assets that work together to lift nodules off the seafloor and up to a purpose-built production vessel, transfer them to a hydrodynamic shuttle carrier, and onward to a metallurgical plant designed to transform an urban port site into a battery materials innovation and community hub, set within a regenerative coastal landscape.
“To collect the nodules, we have designed a light-touch, robotic collector vehicle that aims a jet of seawater across the tops of the rocks to gently pry them from the sediment. Part of our design for future collectors includes a buoyant, hydrodynamic shell with an extended lip to minimize seafloor compaction and reduce and redirect the dust plume kicked up during nodule collection,” said Daniel Sundlin, partner at BIG and partner in charge of the collaboration with The Metals Company.
The Metals Company’s first-generation collector vehicle has been engineered and is currently being built by Allseas in the Netherlands to be deployed for testing early next year.
Nodules are transported through a flexible hose at the top of the collector vehicle to a rigid riser pipe where they are lifted on compressed air bubbles ~4 km up to the surface production vessel, a 216-meter-long ship that runs on carbon-neutral electrofuels, with a sunken deck that is covered with photovoltaic solar panels. The streamlined design of the production vessel is driven by functionality. Equipment for nodule collection is strategically packed in the hull to minimize the size of the vessel and maximize operational efficiency. At scale, each production vessel would operate multiple collectors with additional maintenance capacity provided by a support vessel with a ‘moon pool’ for deploying and retrieving collector vehicles.
While The Metals Company’s first production vessel is a deep-water drillship repurposed by Allseas to enable pilot nodule collection, BIG’s next generation vessel design is central to The Metals Company’s plans to scale to a fleet of 10 production vessels, enabling the provision of over 40 million tons of battery metals by 2050, enough to produce 280 million electric vehicles (EVs)—a quarter of the global passenger car fleet.
At full-scale operations, nodules will be transferred from the production vessels to shuttle carriers, whose X-bow design was chosen by BIG to deliver hyper-efficient, hydrodynamic ships to further assist The Metals Company in lowering the carbon footprint of its battery metals. Once at port, the nodules are offloaded onto a conveyor and into a portside processing plant—designed by BIG as a sustainable, performative and social campus in a regenerative landscape that turns conventional metallurgy on its head.
“Deep-water ports around the world are often degraded ecosystems unwelcoming to local communities. We asked BIG to reimagine what a metals-processing facility could be, to have it integrate with—even remediate—the urban coastal environment,” said The Metals Company Chairman and CEO, Gerard Barron. “The result is a breathtaking innovation complex that will transform an industrial port into a community-based hub for the electric vehicle revolution.”
“The global energy system needs to undergo its most profound change in centuries to realize a world run exclusively on renewable sources. If the ongoing research and studies conclude that harvesting minerals from the seabed can be done in an environmentally and socially responsible way, we will not only be able to accelerate the green transition but give form to an entirely new industry that will create a sustainable circular metals economy for future generations,” said Founder and Creative Director in BIG-Bjarke Ingels Group, Bjarke Ingels.
BIG, well known for creating a ski slope on a waste-to-energy plant in Copenhagen, designed The Metals Company’s circular, zero-solid-waste metallurgical plant to contain pyrometallurgical processing and hydrometallurgical refining steps, stockpiles, and product storage alongside offices, visitor-centric experiences, and an innovation center to tie products into the EV supply chain. The company envisions multiple facilities spread across three continents and a number of brownfield sites are currently under consideration. These plants would in time be retooled to recycle battery cathodes at end-of-life, closing the loop on the battery metals supply chain.
“The world is characterized by a mindset that divides the world into front of house and back of house. The front of house is carefully designed in the form of beautiful facades and lush parks, leaving the back of house as purely utilitarian and logistical leftovers in the form of parking lots and warehouses. With The Metals Company, we are designing a human made ecosystem channeling the flow of resources with the care and attention conventionally reserved for the front of house. A next-generation materials industry,” said Bjarke Ingels.
“We’re remaking how society gets, uses and ultimately re-uses the base metals which form the foundation of the clean energy economy,” said Barron. “BIG has delivered these radical, low-impact designs to help us remake an industry. Now the exciting question is, which port will we transform first?”
ABOUT THE METALS COMPANY
The Metals Company is a Canadian developer of lower-impact battery metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for the clean energy transition with the least possible negative environmental and social impact and (2) accelerate the transition to a circular metal economy. The company through its subsidiaries holds exploration and commercial rights to three polymetallic nodule contract areas in the Clarion Clipperton Zone of the Pacific Ocean regulated by the International Seabed Authority and sponsored by the governments of Nauru, Kiribati and the Kingdom of Tonga. In March, The Metals Company announced that it had entered into a business combination agreement with Sustainable Opportunities Acquisition Corporation (SOAC) to accelerate project development and take it public on NASDAQ as ‘The Metals Company’. More information is available at https://www.metals.co/ .
ABOUT BJARKE INGELS GROUP
BIG-Bjarke Ingels Group is a Copenhagen, New York, London, Shenzhen, and Barcelona based group of architects, designers, urbanists, landscape professionals, interior and product designers, researchers and inventors. The office is currently involved in projects throughout Europe, America, Asia and the Middle East. BIG’s architecture emerges out of a careful analysis of how contemporary life constantly evolves and changes. By hitting the fertile overlap between pragmatic and utopia, we architects once again find the freedom to change the surface of our planet, to better fit contemporary life forms.
Find more information at www.big.dk .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005310/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
